Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mitchell L Jones"'
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e115175 (2014)
We performed an analysis to determine the importance of bile acid modification genes in the gut microbiome of inflammatory bowel disease and type 2 diabetic patients. We used publicly available metagenomic datasets from the Human Microbiome Project a
Externí odkaz:
https://doaj.org/article/5445ff611b99467e9ad0562b6ee4c9b5
Publikováno v:
Journal of Functional Foods, Vol 5, Iss 1, Pp 116-123 (2013)
Modification of gut microflora has been reported as altering energy and lipid homeostasis, leading to changes in body composition. We evaluated whether consumption of Lactobacillus amylovorus (LA) and Lactobacillus fermentum (LF) as novel probiotics
Externí odkaz:
https://doaj.org/article/8edcb3d5f8a24a4ea4276853112c1b70
Autor:
Wei, Ouyang, Hongmei, Chen, Mitchell L, Jones, Tasima, Haque, Christopher, Martoni, Fateme, Afkhami, Satya, Prakash
Publikováno v:
Indian journal of biochemistrybiophysics. 46(6)
Oral therapy utilizing cell microencapsulation has shown promise in the treatment of many diseases. Current obtainable microcapsule membranes, however, show inadequate stability in the gastrointestinal (GI) environment, thus restricting the general a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b3c72e5c74df0439e2326ba6190cbef1
https://pubmed.ncbi.nlm.nih.gov/20361712
https://pubmed.ncbi.nlm.nih.gov/20361712
Autor:
Wei, Ouyang, Hongmei, Chen, Mitchell L, Jones, Terrence, Metz, Tasima, Haque, Christopher, Martoni, Satya, Prakash
Publikováno v:
Journal of pharmacypharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 7(3)
Bacterial cells can be engineered to synthesize a wide array of disease modifying substrates such as cytokines, vaccines and antibodies; however, their use as an orally delivered therapeutic is limited by poor gastrointestinal (GI) survival and insti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::edd807d00a44a8bbbfbf169f2971ffa7
https://pubmed.ncbi.nlm.nih.gov/15576011
https://pubmed.ncbi.nlm.nih.gov/15576011
Autor:
Catherine Tomaro-Duchesneau, Satya Prakash, Alain Labbé, Imen Kahouli, Mitchell L. Jones, Shyamali Saha, Meenakshi Malhotra, Michael Coussa-Charley
Publikováno v:
Pharmaceuticals, Vol 5, Iss 2, Pp 236-248 (2012)
Probiotics possess potential therapeutic and preventative effects for various diseases and metabolic disorders. One important limitation for the oral delivery of probiotics is the harsh conditions of the upper gastrointestinal tract (GIT) which chall
Externí odkaz:
https://doaj.org/article/a470281e364b497a873e7ed2288107e4